 | • レポートコード：MRC2Q12-17355 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、薬剤溶出性末梢ステントのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 薬剤溶出性末梢ステントのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 薬剤溶出性末梢ステントの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 薬剤溶出性末梢ステントのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの薬剤溶出性末梢ステントの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の薬剤溶出性末梢ステントの売上および2028年までの予測に焦点を当てています。 薬剤溶出性末梢ステントのグローバル主要企業には、Boston Scientific Corporation、W. L. Gore & Associates、Abbott Laboratories、iVascular SLU.、Meril Life Sciences Pvt. Ltd.、Stentys SA, Cook Medical Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 薬剤溶出性末梢ステント市場は、タイプとアプリケーションによって区分されます。世界の薬剤溶出性末梢ステント市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 頸動脈、腸骨動脈、インフラポップ動脈、腎動脈、頸動脈 【アプリケーション別セグメント】 病院、専門クリニック、外来手術センター/外来患者 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 薬剤溶出性末梢ステント製品概要 - タイプ別市場（頸動脈、腸骨動脈、インフラポップ動脈、腎動脈、頸動脈） - アプリケーション別市場（病院、専門クリニック、外来手術センター/外来患者） - 調査の目的 ・エグゼクティブサマリー - 世界の薬剤溶出性末梢ステント販売量予測2017-2028 - 世界の薬剤溶出性末梢ステント売上予測2017-2028 - 薬剤溶出性末梢ステントの地域別販売量 - 薬剤溶出性末梢ステントの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別薬剤溶出性末梢ステント販売量 - 主要メーカー別薬剤溶出性末梢ステント売上 - 主要メーカー別薬剤溶出性末梢ステント価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（頸動脈、腸骨動脈、インフラポップ動脈、腎動脈、頸動脈） - 薬剤溶出性末梢ステントのタイプ別販売量 - 薬剤溶出性末梢ステントのタイプ別売上 - 薬剤溶出性末梢ステントのタイプ別価格 ・アプリケーション別市場規模（病院、専門クリニック、外来手術センター/外来患者） - 薬剤溶出性末梢ステントのアプリケーション別販売量 - 薬剤溶出性末梢ステントのアプリケーション別売上 - 薬剤溶出性末梢ステントのアプリケーション別価格 ・北米市場 - 北米の薬剤溶出性末梢ステント市場規模（タイプ別、アプリケーション別） - 主要国別の薬剤溶出性末梢ステント市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの薬剤溶出性末梢ステント市場規模（タイプ別、アプリケーション別） - 主要国別の薬剤溶出性末梢ステント市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の薬剤溶出性末梢ステント市場規模（タイプ別、アプリケーション別） - 主要国別の薬剤溶出性末梢ステント市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の薬剤溶出性末梢ステント市場規模（タイプ別、アプリケーション別） - 主要国別の薬剤溶出性末梢ステント市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの薬剤溶出性末梢ステント市場規模（タイプ別、アプリケーション別） - 主要国別の薬剤溶出性末梢ステント市場規模（トルコ、サウジアラビア） ・企業情報 Boston Scientific Corporation、W. L. Gore & Associates、Abbott Laboratories、iVascular SLU.、Meril Life Sciences Pvt. Ltd.、Stentys SA, Cook Medical Inc. ・産業チェーン及び販売チャネル分析 - 薬剤溶出性末梢ステントの産業チェーン分析 - 薬剤溶出性末梢ステントの原材料 - 薬剤溶出性末梢ステントの生産プロセス - 薬剤溶出性末梢ステントの販売及びマーケティング - 薬剤溶出性末梢ステントの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 薬剤溶出性末梢ステントの産業動向 - 薬剤溶出性末梢ステントのマーケットドライバー - 薬剤溶出性末梢ステントの課題 - 薬剤溶出性末梢ステントの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Drug Eluting Peripheral Stents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Drug Eluting Peripheral Stents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Drug Eluting Peripheral Stents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Drug Eluting Peripheral Stents include Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd. and Stentys SA, Cook Medical Inc., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Drug Eluting Peripheral Stents manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Drug Eluting Peripheral Stents market. Further, it explains the major drivers and regional dynamics of the global Drug Eluting Peripheral Stents market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Boston Scientific Corporation
W. L. Gore & Associates
Abbott Laboratories
iVascular SLU.
Meril Life Sciences Pvt. Ltd.
Stentys SA, Cook Medical Inc.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Drug Eluting Peripheral Stents Segment by Type
Carotid Artery
Iliac Artery
Infrapop Artery
Renal Artery
Carotid Artery
Drug Eluting Peripheral Stents Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers/Outpatients
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Eluting Peripheral Stents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Drug Eluting Peripheral Stents, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Drug Eluting Peripheral Stents, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drug Eluting Peripheral Stents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Eluting Peripheral Stents sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Drug Eluting Peripheral Stents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Drug Eluting Peripheral Stents sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd. and Stentys SA, Cook Medical Inc., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drug Eluting Peripheral Stents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drug Eluting Peripheral Stents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Eluting Peripheral Stents sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Drug Eluting Peripheral Stents Product Introduction
1.2 Market by Type
1.2.1 Global Drug Eluting Peripheral Stents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Carotid Artery
1.2.3 Iliac Artery
1.2.4 Infrapop Artery
1.2.5 Renal Artery
1.2.6 Carotid Artery
1.3 Market by Application
1.3.1 Global Drug Eluting Peripheral Stents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers/Outpatients
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug Eluting Peripheral Stents Sales Estimates and Forecasts 2017-2028
2.2 Global Drug Eluting Peripheral Stents Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug Eluting Peripheral Stents Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug Eluting Peripheral Stents Sales by Region
2.4.1 Global Drug Eluting Peripheral Stents Sales by Region (2017-2022)
2.4.2 Global Sales Drug Eluting Peripheral Stents by Region (2023-2028)
2.5 Global Drug Eluting Peripheral Stents Revenue by Region
2.5.1 Global Drug Eluting Peripheral Stents Revenue by Region (2017-2022)
2.5.2 Global Drug Eluting Peripheral Stents Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug Eluting Peripheral Stents Sales by Manufacturers
3.1.1 Global Top Drug Eluting Peripheral Stents Manufacturers by Sales (2017-2022)
3.1.2 Global Drug Eluting Peripheral Stents Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Eluting Peripheral Stents in 2021
3.2 Global Drug Eluting Peripheral Stents Revenue by Manufacturers
3.2.1 Global Drug Eluting Peripheral Stents Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug Eluting Peripheral Stents Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug Eluting Peripheral Stents Revenue in 2021
3.3 Global Drug Eluting Peripheral Stents Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug Eluting Peripheral Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug Eluting Peripheral Stents Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug Eluting Peripheral Stents Sales by Type
4.1.1 Global Drug Eluting Peripheral Stents Historical Sales by Type (2017-2022)
4.1.2 Global Drug Eluting Peripheral Stents Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug Eluting Peripheral Stents Sales Market Share by Type (2017-2028)
4.2 Global Drug Eluting Peripheral Stents Revenue by Type
4.2.1 Global Drug Eluting Peripheral Stents Historical Revenue by Type (2017-2022)
4.2.2 Global Drug Eluting Peripheral Stents Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2017-2028)
4.3 Global Drug Eluting Peripheral Stents Price by Type
4.3.1 Global Drug Eluting Peripheral Stents Price by Type (2017-2022)
4.3.2 Global Drug Eluting Peripheral Stents Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug Eluting Peripheral Stents Sales by Application
5.1.1 Global Drug Eluting Peripheral Stents Historical Sales by Application (2017-2022)
5.1.2 Global Drug Eluting Peripheral Stents Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug Eluting Peripheral Stents Sales Market Share by Application (2017-2028)
5.2 Global Drug Eluting Peripheral Stents Revenue by Application
5.2.1 Global Drug Eluting Peripheral Stents Historical Revenue by Application (2017-2022)
5.2.2 Global Drug Eluting Peripheral Stents Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2017-2028)
5.3 Global Drug Eluting Peripheral Stents Price by Application
5.3.1 Global Drug Eluting Peripheral Stents Price by Application (2017-2022)
5.3.2 Global Drug Eluting Peripheral Stents Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug Eluting Peripheral Stents Market Size by Type
6.1.1 North America Drug Eluting Peripheral Stents Sales by Type (2017-2028)
6.1.2 North America Drug Eluting Peripheral Stents Revenue by Type (2017-2028)
6.2 North America Drug Eluting Peripheral Stents Market Size by Application
6.2.1 North America Drug Eluting Peripheral Stents Sales by Application (2017-2028)
6.2.2 North America Drug Eluting Peripheral Stents Revenue by Application (2017-2028)
6.3 North America Drug Eluting Peripheral Stents Market Size by Country
6.3.1 North America Drug Eluting Peripheral Stents Sales by Country (2017-2028)
6.3.2 North America Drug Eluting Peripheral Stents Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drug Eluting Peripheral Stents Market Size by Type
7.1.1 Europe Drug Eluting Peripheral Stents Sales by Type (2017-2028)
7.1.2 Europe Drug Eluting Peripheral Stents Revenue by Type (2017-2028)
7.2 Europe Drug Eluting Peripheral Stents Market Size by Application
7.2.1 Europe Drug Eluting Peripheral Stents Sales by Application (2017-2028)
7.2.2 Europe Drug Eluting Peripheral Stents Revenue by Application (2017-2028)
7.3 Europe Drug Eluting Peripheral Stents Market Size by Country
7.3.1 Europe Drug Eluting Peripheral Stents Sales by Country (2017-2028)
7.3.2 Europe Drug Eluting Peripheral Stents Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug Eluting Peripheral Stents Market Size by Type
8.1.1 Asia Pacific Drug Eluting Peripheral Stents Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug Eluting Peripheral Stents Revenue by Type (2017-2028)
8.2 Asia Pacific Drug Eluting Peripheral Stents Market Size by Application
8.2.1 Asia Pacific Drug Eluting Peripheral Stents Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug Eluting Peripheral Stents Revenue by Application (2017-2028)
8.3 Asia Pacific Drug Eluting Peripheral Stents Market Size by Region
8.3.1 Asia Pacific Drug Eluting Peripheral Stents Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug Eluting Peripheral Stents Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drug Eluting Peripheral Stents Market Size by Type
9.1.1 Latin America Drug Eluting Peripheral Stents Sales by Type (2017-2028)
9.1.2 Latin America Drug Eluting Peripheral Stents Revenue by Type (2017-2028)
9.2 Latin America Drug Eluting Peripheral Stents Market Size by Application
9.2.1 Latin America Drug Eluting Peripheral Stents Sales by Application (2017-2028)
9.2.2 Latin America Drug Eluting Peripheral Stents Revenue by Application (2017-2028)
9.3 Latin America Drug Eluting Peripheral Stents Market Size by Country
9.3.1 Latin America Drug Eluting Peripheral Stents Sales by Country (2017-2028)
9.3.2 Latin America Drug Eluting Peripheral Stents Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Drug Eluting Peripheral Stents Market Size by Type
10.1.1 Middle East and Africa Drug Eluting Peripheral Stents Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug Eluting Peripheral Stents Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug Eluting Peripheral Stents Market Size by Application
10.2.1 Middle East and Africa Drug Eluting Peripheral Stents Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug Eluting Peripheral Stents Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug Eluting Peripheral Stents Market Size by Country
10.3.1 Middle East and Africa Drug Eluting Peripheral Stents Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug Eluting Peripheral Stents Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Corporation Information
11.1.2 Boston Scientific Corporation Overview
11.1.3 Boston Scientific Corporation Drug Eluting Peripheral Stents Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boston Scientific Corporation Drug Eluting Peripheral Stents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boston Scientific Corporation Recent Developments
11.2 W. L. Gore & Associates
11.2.1 W. L. Gore & Associates Corporation Information
11.2.2 W. L. Gore & Associates Overview
11.2.3 W. L. Gore & Associates Drug Eluting Peripheral Stents Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 W. L. Gore & Associates Drug Eluting Peripheral Stents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 W. L. Gore & Associates Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Overview
11.3.3 Abbott Laboratories Drug Eluting Peripheral Stents Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Laboratories Drug Eluting Peripheral Stents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Laboratories Recent Developments
11.4 iVascular SLU.
11.4.1 iVascular SLU. Corporation Information
11.4.2 iVascular SLU. Overview
11.4.3 iVascular SLU. Drug Eluting Peripheral Stents Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 iVascular SLU. Drug Eluting Peripheral Stents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 iVascular SLU. Recent Developments
11.5 Meril Life Sciences Pvt. Ltd.
11.5.1 Meril Life Sciences Pvt. Ltd. Corporation Information
11.5.2 Meril Life Sciences Pvt. Ltd. Overview
11.5.3 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Meril Life Sciences Pvt. Ltd. Recent Developments
11.6 Stentys SA, Cook Medical Inc.
11.6.1 Stentys SA, Cook Medical Inc. Corporation Information
11.6.2 Stentys SA, Cook Medical Inc. Overview
11.6.3 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Stentys SA, Cook Medical Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug Eluting Peripheral Stents Industry Chain Analysis
12.2 Drug Eluting Peripheral Stents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Eluting Peripheral Stents Production Mode & Process
12.4 Drug Eluting Peripheral Stents Sales and Marketing
12.4.1 Drug Eluting Peripheral Stents Sales Channels
12.4.2 Drug Eluting Peripheral Stents Distributors
12.5 Drug Eluting Peripheral Stents Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug Eluting Peripheral Stents Industry Trends
13.2 Drug Eluting Peripheral Stents Market Drivers
13.3 Drug Eluting Peripheral Stents Market Challenges
13.4 Drug Eluting Peripheral Stents Market Restraints
14 Key Findings in The Global Drug Eluting Peripheral Stents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer